India’s COVID-19 Crisis: Variants, Vaccines and Surges

India’s COVID-19 Crisis: Variants, Vaccines and Surges

Presented jointly with Reuters

Thursday, May 13, 2021

12 pm ET

This Q&A will stream on Facebook , YouTube, and on The Forum website.

India is experiencing a catastrophic surge of coronavirus cases — more than 22.66 million confirmed cases with more than 240,000 deaths. What can be done to help the situation in India, as well as in other countries, especially those with limited resources and low vaccination rates? In this live Q&A, K. “Vish” Viswanath, Director of the Harvard Chan India Research Center, and Louise Ivers, Executive Director of the MGH Center for Global Health, talk with Reuters’ Kate Kelland about the devastating situation in India and the lessons offered for the rest of the world. Email your viewer questions to theforum@hsph.harvard.edu or post your questions to Facebook @ForumHSPH.

MODERATOR

Kate Kelland, Global Consumer Health Correspondent, Reuters

SPEAKERS

Louise Ivers, Executive Director, MGH Center for Global Health, and Professor of Medicine at Harvard Medical School

K. “Vish” Viswanath, Director, Harvard Chan India Research Center, and Lee Kum Kee Professor of Health Communication in the Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, and in the McGraw-Patterson Center for Population Sciences at the Dana-Farber Cancer Institute